Editorial on the Special Issue “The New Frontier of Venous Thromboembolism”-Reference-Cited by-同舟云学术

Editorial on the Special Issue “The New Frontier of Venous Thromboembolism”

Published:2023-10-17 Issue:10 Volume:13 Page:2071
ISSN:2075-1729
Container-title:Life
language:en
Short-container-title:Life

Author:

Di Micco Pierpaolo¹^ORCID,Imbalzano Egidio²^ORCID,Camporese Giuseppe³^ORCID

Affiliation:

1. AFO Medicina, UOC Medicina Interna, P.O. Santa Maria delle Grazie, ASL NA2 Nord, 80078 Pozzuoli, Italy

2. Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy

3. General Medicine Unit, Thrombotic and Haemorrhagic Disorders Unit, Department of Internal Medicine, University Hospital of Padua, 35128 Padua, Italy

Abstract

In recent years, great efforts have been made to improve decision making in caring for patients of venous thromboembolism (VTE) [...]

Publisher

MDPI AG

Subject

Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics

Link

https://www.mdpi.com/2075-1729/13/10/2071/pdf

Reference8 articles.

1. Rydell, H., Huge, Y., Eriksson, V., Johansson, M., Alamdari, F., Svensson, J., Aljabery, F., and Sherif, A. (2022). Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. Life, 12.

2. Zalunardo, B., Panzavolta, C., Bigolin, P., and Visonà, A. (2022). Multidisciplinary Care for the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer-Associated Thrombosis (CAT): Impact of Educational Interventions on CAT-Related Events and on Patients’ and Clinicians’ Awareness. Life, 12.

3. Bernardi, E., Camporese, G., Bortoluzzi, C., Noventa, F., Ceccato, D., Tonello, C., Vohong, S., Campello, E., Simion, C., and Imbalzano, E. (2022). Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project. Life, 12.

4. Bortoluzzi, C., Bernardi, E., Camporese, G., Noventa, F., Ceccato, D., Tonello, C., Vo Hong, N., Campello, E., Simion, C., and Imbalzano, E. (2022). Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project. Life, 12.

5. Di Micco, P., Salazar, V.R., Capitan, C.F., Dentali, F., Cuervo, C.G., Reyes, J.L.F., Porras, J.A., Fidalgo, A., Grandone, E., and Meseguer, M.L. (2022). Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy. Life, 12.